Invention Grant
US08933213B2 Antisense modulation of fibroblast growth factor receptor 4 expression
有权
成纤维细胞生长因子受体4表达的反义调控
- Patent Title: Antisense modulation of fibroblast growth factor receptor 4 expression
- Patent Title (中): 成纤维细胞生长因子受体4表达的反义调控
-
Application No.: US13631437Application Date: 2012-09-28
-
Publication No.: US08933213B2Publication Date: 2015-01-13
- Inventor: Sanjay Bhanot , Xing Xian Yu , Michael L. McCaleb
- Applicant: Isis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Knobbe, Martens, Olson & Bear LLP
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K31/711 ; A61K45/06 ; C12N15/113
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of fibroblast growth factor receptor 4 (FGFR4) mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a metabolic disease, or a symptom thereof.
Public/Granted literature
- US20130281509A1 ANTISENSE MODULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 4 EXPRESSION Public/Granted day:2013-10-24
Information query
